Deals & Cases

KARL STORZ acquires Anklin

27. Januar 2025 – The Swiss company Anklin, based in Reinach, is now part of the KARL STORZ direct sales network, ensuring continuous operational excellence and closer customer relations. The transaction brings KARL STORZ closer to its customers and their individual needs regarding products and services and is in line with its strategy to further expand direct sales, while it allows the Anklin family to secure their succession and transfer the highly successful company to a new owner.

Founded in 1948 and headquartered in Reinach BL, Switzerland, Anklin is a distributor of high-precision medical instruments and devices in the field of endoscopy for human and veterinary medicine. Known for its exceptional service quality, Anklin has established itself as a very well-known brand in Switzerland. With a successful history of collaboration with KARL STORZ, Anklin has continually advanced its offerings to meet the evolving needs of the medical endoscopes industry. The company serves the entire Swiss market in all language regions and employs a dedicated team of around 70 specialists.

Founded in 1954 in Tuttlingen, Germany, KARL STORZ is a global leader in endoscopy and medical instruments. The family-owned company, now in its third generation, employs 9’400 people across more than 40 countries. KARL STORZ offers a diverse portfolio of 13’000 products for both human and veterinary medicine. In 2023, the company reported sales of 2.17 billion euros. KARL STORZ operates production sites in Germany, the USA, Switzerland, and Estonia.

Walder Wyss advised the Anklin family in this transaction. The team was led by Robert von Rosen (Partner, Corporate/M&A) and further included Christoph Burckhardt (Senior Associate, Corporate/M&A), Simon Olstein (Senior Associate, Corporate/M&A), Tizian Troxler (Associate, Corporate/M&A), Oerjan Wickart (Associate, Corporate/M&A), Philippe Nordmann (Partner, Employment), Jonas Knechtli (Managing Associate, Employment, Andrea Haefeli (Counsel, Corporate/Commercial), Celine Weber (Managing Associate, Life Science), Mirjam Olah (Senior Associate, Corporate/Life Science) and Yannick A. Moser (Managing Associate, Real Estate).